Jordi Esteve Reyner

49PUBLICATIONS
270CO-AUTHORS
Haematological tumoursHaematologyGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 13, 2026
Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities.

|Apr 22, 2026
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).

|Dec 24, 2025
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations.

Iman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poire

|Nov 29, 2025
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party.

Marta Villalba, Allain-Thibeault Ferhat, Tobias Gedde-Dahl

|Oct 16, 2025
Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry.

Arnon Nagler, Jordi Esteve, Jacques-Emmanuel Galimard

|Aug 18, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Uwe Platzbecker, Lionel Adès, Pau Montesinos

Pageof 9

Frequent Collaborators

17 joint publications

Mohamad Mohty

13 joint publications

Arnon Nagler

10 joint publications

Fabio Ciceri

10 joint publications

Myriam Labopin